Loading
A phase 2 trial of benmelstobart, anlotinib and etoposide in lung cancer, run by Yayi He, not yet recruiting.
A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer is a phase 2, interventional study registered as NCT07538271 by Yayi He, with a registry enrolment figure of 33 participants, started 2026-04-20 and due to reach its primary completion in 2027-09-30. Interventions recorded: benmelstobart; Anlotinib; Carboplatin or cisplatin; Etoposide; Thoracic Radiotherapy. Conditions listed: SCLC, Extensive Stage. Primary outcome: Objective Response Rate (ORR). Lung eligibility wording from the registry: "* 1: Histologically or cytologically confirmed inoperable extensive-stage small cell lung cancer (ES-SCLC) according to the VALG staging system". No results are recorded here; the registry entry is the source.
Shares Benmelstobart, Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing), Anti-angiogenic therapy and the tag lung-deep-dive.
Shares Anlotinib, Etoposide, Anti-angiogenic therapy, Topoisomerase-I inhibitors (and ADC payloads) and the tag lung-deep-dive.
Shares Anlotinib, Extensive-stage small-cell lung cancer, Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing), Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Etoposide, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing), Extensive-stage small-cell lung cancer, Anti-angiogenic therapy and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Etoposide, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Anlotinib, Anti-angiogenic therapy, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.